PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023.

On October 13, 2022, the Shenzhen Stock Exchange disclosed that the 73rd Review Meeting of the GEM Listing Committee in 2022 was held and approved Jiaxing Quaero Life Science Co., Ltd. to be listed on the Sci-Tech Innovation Board.

GE published a regulatory filing about the spinoff of its healthcare unit, which it expects to complete in the first week of 2023, if the transaction is approved by its board of directors. GE HealthCare will be listed on the Nasdaq under the ticker “GEHC.”

QuidelOrtho on Wednesday reported preliminary third quarter revenues of between $782 million and $785 million.

Gongdong Medical recently released its 2022 semi-annual report, in which the company achieved operating revenue of CNY 799 million, an increase of 38.70% year-on-year; net profit attributable to shareholders of the listed company was CNY 211 million, an increase of 18.92% year-on-year.

On March 2, the FTSE Russell Day announced the results of the quarterly audit changes of the FTSE China A50 and other indices.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 8 percent year over year.

On February 23, Lepu Biopharma Co., Ltd. was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2157.HK. The issue price is HKD 7.13 per share, and public offering raised about HKD 900 million.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.

Roche on Thursday reported a 29 percent year-over-year increase in sales in its diagnostics division for full-year 2021, driven by momentum in the base business and continued demand for COVID-19 testing.